W Kenneth Ward

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. pmc The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in Type 1 diabetes
    W K Ward
    Legacy Health System, Legacy Research Institute, Portland, OR 97232, USA
    Diabet Med 29:1067-73. 2012
  2. pmc Analysis: continuous glucose monitoring in the intensive care unit
    W Kenneth Ward
    Oregon Health and Science University, Legacy Health, Portland, OR 97239, USA
    J Diabetes Sci Technol 6:1372-4. 2012
  3. pmc A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis
    W Kenneth Ward
    Legacy Clinical Research and Technology Center and Oregon Health and Science University, Portland, Oregon, USA
    J Diabetes Sci Technol 2:768-77. 2008
  4. pmc Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia
    W Kenneth Ward
    Oregon Health and Science University, Portland, Oregon 97239, USA
    J Diabetes Sci Technol 5:1373-80. 2011
  5. pmc In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effect
    W Kenneth Ward
    Legacy Health System Research, Portland, Oregon 97232, USA
    J Diabetes Sci Technol 4:1311-21. 2010

Collaborators

Detail Information

Publications5

  1. pmc The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in Type 1 diabetes
    W K Ward
    Legacy Health System, Legacy Research Institute, Portland, OR 97232, USA
    Diabet Med 29:1067-73. 2012
    ..It is unclear whether the magnitude of sensor lag is lower during falling glucose than during rising glucose...
  2. pmc Analysis: continuous glucose monitoring in the intensive care unit
    W Kenneth Ward
    Oregon Health and Science University, Legacy Health, Portland, OR 97239, USA
    J Diabetes Sci Technol 6:1372-4. 2012
    ..Ideally, further development of this quite promising catheter-based device would allow it to be used also to deliver fluids and drugs, thus avoiding the need for a second catheter elsewhere...
  3. pmc A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis
    W Kenneth Ward
    Legacy Clinical Research and Technology Center and Oregon Health and Science University, Portland, Oregon, USA
    J Diabetes Sci Technol 2:768-77. 2008
    ....
  4. pmc Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia
    W Kenneth Ward
    Oregon Health and Science University, Portland, Oregon 97239, USA
    J Diabetes Sci Technol 5:1373-80. 2011
    ..Elements such as the use of glucagon to minimize hypoglycemia, adaptation to changes in insulin sensitivity, and sensor redundancy will likely increase safety during outpatient use of closed-loop glycemic control systems...
  5. pmc In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effect
    W Kenneth Ward
    Legacy Health System Research, Portland, Oregon 97232, USA
    J Diabetes Sci Technol 4:1311-21. 2010
    ..However, under some conditions, solutions of glucagon can form amyloid fibrils. Currently, the usage instructions for commercially available glucagon allow only for its immediate use...